A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Vanderbilt University
Mayo Clinic
Roswell Park Cancer Institute
M.D. Anderson Cancer Center